文献速递脑血管病

大血管闭塞性缺血性卒中联合血管内取栓与静脉溶栓的获益幅度

Magnitude of Benefit of Combined Endovascular Thrombectomy and Intravenous Fibrinolysis in Large Vessel Occlusion Ischemic Stroke.
PubMed 文献 · Stroke · 2019-07-17

本研究通过匹配NINDS rt-PA试验和SWIFT PRIME试验中前循环大血管闭塞患者,比较无再灌注治疗、单纯静脉溶栓和静脉溶栓联合血管内取栓的预后。匹配240例患者后,联合治疗组3个月无残疾率48.1%显著高于无再灌注组的21.3%,功能独立率62.9%对32.6%,总体残疾减少的common OR为3.34。联合治疗每治疗1.8例即可多1例残疾减少。

要点

  • 联合静脉溶栓和取栓较无再灌注显著提高无残疾和功能独立率。
  • 联合治疗总体残疾减少的common OR为3.34,获益显著。
  • 单纯静脉溶栓较无再灌注的获益未达统计学显著。

核心结论

  • 联合静脉溶栓和机械取栓是大血管闭塞性急性缺血性卒中的高效治疗策略。
  • 每100例接受联合再灌注治疗的患者中,57例长期残疾减少,其中30例获得功能独立。

研究设计与样本

  • 匹配NINDS rt-PA试验和SWIFT PRIME试验患者,基于年龄、NIHSS评分及前循环大血管闭塞可能性进行最优逆方差匹配。
  • 匹配后共240例,无再灌注、单纯静脉溶栓和联合治疗各80例。

主要发现

  • 联合治疗组无残疾(mRS 0-1)48.1%,无再灌注组21.3%,P=0.0004。
  • 联合治疗组功能独立(mRS 0-2)62.9%,无再灌注组32.6%,P=0.0001。
  • 联合治疗组总体残疾减少的common OR为3.34,P<0.0001。
  • 单纯静脉溶栓组无残疾30.0%对21.3%,P=0.28;总体残疾减少common OR 1.14,P=0.65。
  • 联合治疗每多1例残疾减少的需治疗人数(NNT)为1.8。

关键数值与推荐

  • 联合治疗组平均年龄66.9岁,基线NIHSS平均15.9。
  • 无再灌注组平均年龄67.1岁,基线NIHSS平均15.8。
  • 单纯静脉溶栓组平均年龄67.1岁,基线NIHSS平均15.9。

临床怎么用

  • 对于前循环大血管闭塞的急性缺血性卒中患者,应优先考虑静脉溶栓联合血管内取栓治疗。
  • 联合治疗可显著提高3个月功能独立率并减少长期残疾。

局限性

  • 研究基于两项随机试验患者的匹配分析,非直接头对头随机比较。
  • 样本量有限,匹配后每组80例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Quantifying the benefit magnitude of combined endovascular thrombectomy (EVT) and intravenous thrombolysis (IVT) versus nonreperfusion care in patients with acute ischemic stroke caused by large vessel occlusion would aid organization of regional stroke care systems. Methods- NINDS rt-PA Study (National Institute for Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator) and SWIFT PRIME trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment) patients were matched for prognosis (based on age and National Institutes of Health Stroke Scale) and definite/likely anterior circulation large vessel occlusion (based on National Institutes of Health Stroke Scale total score and item pattern), using optimal inverse variance matching, to determine comparative outcomes with nonreperfusion care alone, IVT alone, and IVT+EVT. Results- Matching yielded 240 patients, including 80 each treated with nonreperfusion care, IVT alone, and IVT+EVT, with, respectively, mean age 67.1, 67.1, and 66.9 and presenting deficit severity (National Institutes of Health Stroke Scale) mean 15.8, 15.9, and 15.9. Outcomes at 3 months for IVT+EVT versus nonreperfusion care included freedom from disability (modified Rankin Scale score, 0-1) 48.1% versus 21.3%, P=0.0004; functional independence (modified Rankin Scale score, 0-2) 62.9% versus 32.6, P=0.0001; and reduced disability over all 7 modified Rankin Scale levels, common odds ratio 3.34, P<0.0001. Outcomes for IVT alone versus nonreperfusion care included: freedom from disability 30.0% versus 21.3%, P=0.28 and reduced disability over all 7 modified Rankin Scale levels, common odds ratio 1.14, P=0.65. Compared with nonreperfusion care, the number needed to treat with EVT+IVT for 1 more patient to have reduced disability was 1.8. Conclusions- Matched patient analysis across randomized trials provides evidence that the strategy of combined IVT and mechanical thrombectomy is a highly beneficial treatment strategy for acute ischemic stroke caused by large vessel occlusion patients. A reasonable effect magnitude estimate is that, among every 100 patients treated, combined IVT+EVT reperfusion therapy, compared with no reperfusion therapy, reduces long-term disability in 57, including conferring functional independence upon 30.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Young-Saver DF, Gornbein J, Starkman S, et al. Magnitude of Benefit of Combined Endovascular Thrombectomy and Intravenous Fibrinolysis in Large Vessel Occlusion Ischemic Stroke. Stroke. 2019. PMID: 31311465. doi:10.1161/STROKEAHA.118.023120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。